(177)Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer

The aim of this narrative review is to evaluate the current status of (177)Lu-PSMA (prostate specific membrane antigen) therapy for metastatic castration-resistant prostate cancer (mCRPC) in the light of the current literature. We also addressed patient preparation, therapy administration and side e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomedicines
Main Authors: Sanli, Yasemin, Simsek, Duygu Has, Sanli, Oner, Subramaniam, Rathan M., Kendi, Ayse Tuba
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071500/
https://ncbi.nlm.nih.gov/pubmed/33921146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9040430
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares